Thalidomide-piperazine-Boc
Thalidomide-piperazine-Boc is an intermediate that can be used in the synthesis of B-cell lymphoma 6 protein (BCL6) PROTAC[1].
Product Specifications
CAS Number
2222114-64-7
UNSPSC
12352005
Hazard Statement
H301, H312, H361
Target
Apoptosis; Autophagy; E3 Ligase Ligand-Linker Conjugates
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/thalidomide-piperazine-boc.html
Purity
98.82
Solubility
DMSO : 41.67 mg/mL (ultrasonic)
Smiles
O=C(N1CCN(C2=CC3=C(C(N(C(CC4)C(NC4=O)=O)C3=O)=O)C=C2)CC1)OC(C)(C)C
Molecular Formula
C22H26N4O6
Molecular Weight
442.47
Precautions
H301, H312, H361
References & Citations
[1]Michael Berlin, et al. Bifunctional molecules containing an e3 ubiquitine ligase binding moiety linked to a bcl6 targeting moiety. WO2021077010A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cereblon
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MAGE A1 (MA454), CF405S conjugate, 0.1mg/mL
CD59 (heavy chain of Protectin) (BRA-10G), Biotin conjugate, 0.1mg/mL
Cytokeratin 8 (KRT8) (B22.1), CF640R conjugate, 0.1mg/mL
